| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 628591 | Null | 0.0202245331784479 | 0.45611802 |
| NSC 634794 | Null | 0.0202245331784479 | 0.21736318 |
| NSC 639516 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride | 0.0202245331784479 | 0.37243592 |
| NSC 639518 | Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride | 0.0202245331784479 | 0.46643632 |
| NSC 651650 | Null | 0.0202245331784479 | 0.27875453 |
| NSC 655901 | ANTINEOPLASTIC-655901 | 0.0202245331784479 | 0.3223732 |
| NSC 658088 | Null | 0.0202245331784479 | 0.17268406 |
| NSC 665104 | Null | 0.0202245331784479 | 0.36241378 |
| NSC 668254 | Null | 0.0202245331784479 | 0.33236884 |
| NSC 670226 | trans-2((1-(4-fluorphenyl-methyl)-4-tert.butylcyclohexyl)oxy)N,N-dimethyl-1-ethanamine-, salt with fumaric acid | 0.0202245331784479 | 0.43859706 |